Br J Cancer  1983 Sep;48(3):417-21 

Effect of clofibrate on the growth-kinetics of the murine P 1798(sc) lymphoma.

Ubeira FM, Seoane R, Puentes E, Faro J, Regueiro BJ.

Clofibrate (CPIB) is a drug applied as an antilipidaemic agent in mammals. In
this work we have tested its efficacy in vivo on the growth kinetics of P
1798(sc) lymphoma transplanted to recipient (BALB/c x AKR)F1 mice. Our results
show a facilitation of the tumour growth rate in treated recipients. This fact
may be related to an effect of the agent on the recipient which produces a
decrease in the immune response as was confirmed on testing CPIB on
thymus-dependent antigens in haemolytic plaque assays.